Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Margolin

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancerYun Yen, Kim Margolin, James Doroshow, et al.
Cancers|June 19, 2024
Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced MelanomaAndrew Tam, Colton Ladbury, Ari Kassardjian, et al.
Investigational New Drugs|May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancyDean Lim, Robert J Morgan, Steven Akman, et al.
Cancer|July 12, 2005
CCI-779 in metastatic melanoma: a phase II trial of the California Cancer ConsortiumKim Margolin, Jeffrey Longmate, Tracey Baratta, et al.
SAGE Open Medical Case Reports|August 30, 2021
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literatureYolanda Piña, Brittany R Evernden, Nikhil Khushalani, et al.
Current Oncology Reports|November 8, 2024
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art ReviewVivek Podder, Shreyas Bellur, Kim Margolin, et al.
Clinical Genitourinary Cancer|October 16, 2012
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivorsSumanta K Pal, Jonathan Yamzon, Virginia Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostineHarry Openshaw, Karen Beamon, Timothy W Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic MelanomaDirk Schadendorf, F Stephen Hodi, Caroline Robert, et al.
Anticancer Research|February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumorsThehang Luu, Warren Chow, Dean Lim, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancerYun Yen, Kim Margolin, James Doroshow, et al.
Cancers|June 19, 2024
Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced MelanomaAndrew Tam, Colton Ladbury, Ari Kassardjian, et al.
Investigational New Drugs|May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancyDean Lim, Robert J Morgan, Steven Akman, et al.
Cancer|July 12, 2005
CCI-779 in metastatic melanoma: a phase II trial of the California Cancer ConsortiumKim Margolin, Jeffrey Longmate, Tracey Baratta, et al.
SAGE Open Medical Case Reports|August 30, 2021
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literatureYolanda Piña, Brittany R Evernden, Nikhil Khushalani, et al.
Current Oncology Reports|November 8, 2024
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art ReviewVivek Podder, Shreyas Bellur, Kim Margolin, et al.
Clinical Genitourinary Cancer|October 16, 2012
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivorsSumanta K Pal, Jonathan Yamzon, Virginia Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostineHarry Openshaw, Karen Beamon, Timothy W Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic MelanomaDirk Schadendorf, F Stephen Hodi, Caroline Robert, et al.
Anticancer Research|February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumorsThehang Luu, Warren Chow, Dean Lim, et al.
Pageof 10